AzTrials
AzTrials

Corneal TransplantationNCT03105466

Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea

A study testing Deep anterior lamellar keratoplasty, Acellular Porcine Cornea and Tacrolimus eye drops in people with Corneal Transplantation, run by Zhongshan Ophthalmic Center, Sun Yat-sen University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record

Search all trials

Trial summary

The performance of keratoplasty is hampered by the limited availability of donor cornea in many countries, especially in Asia. For this reason, attempts have been made to fabricate artificial substitutes for natural human cornea. Read more about this study

Who is it for?
Any age
Conditions the study is for
Corneal Transplantation
What is being tested?
Deep anterior lamellar keratoplasty, Acellular Porcine Cornea and Tacrolimus eye drops
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteChina
Study dates
Feb 2016to Feb 2020
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • corneal diseases not involving the endothelial layer

Who cannot join

  • corneal diseases involving the endothelial layer
  • allergic to pig tissue
  • do not accept xenotransplantation

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Zhongshan Ophthalmic Center, Sun Yat-Sen University

    Guangzhou, Guangdong, 510080

    Saiqun Li, M.D., Ph.D., 86-013642710612, 123213197@qq.com

    Jin Yuan, M.D., Ph.D.

    Recruiting

Other trials in China

About this study

The performance of keratoplasty is hampered by the limited availability of donor cornea in many countries, especially in Asia. For this reason, attempts have been made to fabricate artificial substitutes for natural human cornea. So far, all polymeric biomaterials, such as collagen configurations and plastic compression, could mimic the functional optically transparent but failed to replicate the complicate three-dimension microstructure of natural cornea. Therefore, despite some favorable results yielded by polymeric biomaterials, they cannot be suited for long-term use. To overcome these disadvantages, in recent years, porcine cornea appeared specifically attractive for xenotransplantation, because of its accessibility and similarities to natural human cornea. However, xenotransplantation using fresh porcine cornea can occurs hyperacute immune rejection, resulting in graft failure. Such transplant rejection can be substantially lessened by using acellular porcine cornea (APC), which preserves the constructure of natural cornea, whilst having well biocompatibility and low antigenicity. These properties feature APC particularly suitable for high-risk keratoplasty, such as corneal grafting in infectious keratitis.

Use of APC in LK has been shown promise in many preclinical animal studies and initially in human clinic trail. However, to optimize APC biological and biomechanical properties, the strategies for its preparation has evolved extensively over recent years, like various decellularization approaches (e.g. detergents, enzymes, human sera, hypertonic solutions and et al) and additional procedures (e.g. collagen re-crosslinking and repeated frozen-dry). Therefore, in the current study, the investigators analyzed the early surgical outcomes of deep anterior lamellar keratoplasty (DALK) using the APC that was very recently approved by the National Institutes for Food and Drug Control (NIFDC) of China for clinic practice, for management of infective keratitis, including fungal, viral and acanthamoeba keratitis. Here major concern of this study was to clarify the behavior of APC after implantation in participants.

Being tested
Deep anterior lamellar keratoplasty, Acellular Porcine Cornea, Tacrolimus eye drops, Tobradex eyedrops
Keywords
Corneal Transplantation, Xenotransplantation, Bioegineered cornea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Deep anterior lamellar keratoplastyProcedure or surgery

    Deep anterior lamellar keratoplasty using acellular porcine cornea; 0.05%Tacrolimus eye drops, four times a day for at least one year; 0.3% Tobradex eyedrops, four times-one times a day for one year.

  • Acellular Porcine CorneaDevice

  • Tacrolimus eye dropsDrug

  • Tobradex eyedropsDrug

Study groups in NCT03105466
Study groupRoleWhat they receive
Acellular porcine cornea groupExperimentalParticipants with corneal diseases not involving the endothelial layer undergo deep anterior lamellar keratoplasty using acellular porcine cornea
Receives: Procedure: Deep anterior lamellar keratoplasty; Device: Acellular Porcine Cornea; Drug: Tacrolimus eye drops; Drug: Tobradex eyedrops

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the changes of Best corrected visual acuity

    Measured: Before surgery, 1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery

Secondary outcomes (5)
  1. the changes of visual contrast sensitivity

    Measured: Before surgery, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery

  2. the changes in the transparency of graft

    using Slit lamp microscopic evaluation

    Measured: 1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery

  3. The changes in corneal thickness depth

    using anterior segmental OCT

    Measured: 1-week, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery

  4. The changes in corneal nerve regeneration

    using Confocal microscopy

    Measured: 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery

  5. The changes of depression and anxiety status

    Using Self-Rating Depression Scale (SDS) and Self-Rating Anxiaty Scale (SAS)

    Measured: Before surgery, 1-month, 3-month, 6-month, 1-year, 2-year, 3-year, 4-year after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2017
  2. Study startFeb 2016
  3. Primary completionFeb 2020 (estimated)
  4. Study completionFeb 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03105466
Sponsor's protocol ID
2016021
Status last verified
Apr 2017
First submitted
31 Aug 2016
Last updated
10 Apr 2017
Results posted
No

Publications

  • Li S, Li M, Gu L, Peng L, Deng Y, Zhong J, Wang B, Wang Q, Xiao Y, Yuan J. Risk factors influencing survival of acellular porcine corneal stroma in infectious keratitis: a prospective clinical study. J Transl Med. 2019 Dec 30;17(1):434. doi: 10.1186/s12967-019-02192-z.

    PubMed 31900186

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in